Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 1:08 AM
Ignite Modification Date:
2025-12-25 @ 11:20 PM
NCT ID:
NCT01898793
Group ID:
EG002
Title:
Phase I Dose Level 3: Maximum NK Cell/Number kg
Description:
* Lymphodepleting Preparative Regimen: Patients receive fludarabine phosphate IV over 1 hour on days -6 to -2 and cyclophosphamide IV over 2 hours on days -5 and -4.
* Donor Leukapheresis: Peripheral blood cells are collected from haploidentical related donors over 5 hours on day -1.
* CIML NK Cells: Patients undergo CIML NK cell infusion over 15-60 minutes on day 0.
* Interleukin-2: Patients receive aldesleukin SC every other day for 2 weeks starting on day 1 (total of 7 doses)
Deaths Number Affected:
8
Deaths Number At Risk:
None
Serious Number Affected:
2
Serious Number At Risk:
9
Other Number Affected:
9
Other Number At Risk:
9
Study:
NCT01898793
Results Section:
NCT01898793
Adverse Events Module:
NCT01898793